Eye Patient Adherence and Compliance Study
NCT07793474 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189
Last updated 2026-08-28
Summary
This study looks at ways to help people with glaucoma take their eye drops regularly and attend their clinic appointments. Each participant will be asked about the main challenges they face, such as forgetfulness, difficulty using drops, lack of transportation, or limited understanding of their condition. Based on their biggest challenge, participants will receive one type of support that is already part of usual care, such as education, reminders, help with applying drops, or assistance getting to appointments. The investigators will follow participants over time to see if this support improves how well they follow their treatment and their quality of life.
Conditions
- Glaucoma Medication Adherence
- Glaucoma Patients
Interventions
- BEHAVIORAL
-
Eye Droppers
Participants in this arm receive individualized training and support to improve correct and consistent instillation of glaucoma eye drops. The intervention includes in-person or virtual instruction by the Eye Patient Adherence and Compliance Study-Intervention Program (EYE-PACIP) team on proper drop technique, use of assistive devices where needed, and caregiver training when applicable. Patients with significant physical or cognitive limitations may receive additional volunteer or home-care support. In long-term care settings, coordination with facility staff ensures adherence support. Reinforcement is provided through demonstration, return-demonstration, and follow-up monitoring of technique and adherence.
- BEHAVIORAL
-
Eye Educate
Participants receive structured glaucoma education aimed at improving disease understanding, treatment awareness, and motivation for adherence. Education is delivered through one-on-one or group sessions at the clinic and includes standardized materials (pamphlets, videos, and resources from recognized ophthalmology organizations). Content covers disease chronicity, importance of lifelong treatment, risks of non-adherence, and medication side effects. Pre- and post-intervention assessments are used to evaluate knowledge improvement.
- BEHAVIORAL
-
Eye Coordinate
This arm provides adherence support through structured reminder systems designed to reduce forgetfulness. Interventions include mobile phone alarms, calendar reminders, and physical reminder cards to track medication use. Weekly follow-up calls are conducted during the first month, followed by scheduled check-ins at 3, 6, and 12 months. Patients also report missed doses through logs or reminder tools, which are reviewed during follow-up to reinforce adherence behaviours.
- BEHAVIORAL
-
Eye Help
Participants receive assistance to overcome transportation-related barriers to clinic attendance. The intervention includes coordination with community transportation services (e.g., volunteer drivers, community transport programs) and linkage to available support services. For patients in long-term care or retirement homes, mobile or outreach-based support may be arranged to facilitate continuity of follow-up care. The goal is to improve clinic attendance and reduce missed appointments.
- BEHAVIORAL
-
Eye Refer
Participants receive enhanced access to ophthalmic assessment through mobile or outreach-based clinical support. A trained ophthalmic technician conducts home or facility-based assessments, including intraocular pressure measurement, optic nerve imaging, and portable visual field testing. Findings are reviewed by an ophthalmologist to guide timely management decisions. The intervention also includes strengthened referral coordination to reduce delays in specialist care and improve continuity between primary and specialist services.
Sponsors & Collaborators
-
St. Joseph's Healthcare Hamilton
lead OTHER
Principal Investigators
-
Enitan A. Sogbesan, M.D. · McMaster University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2027-12-31
- Completion
- 2028-03-31
Countries
- Canada
Study Locations
More Related Trials
-
Development and Implementation of an Educational Program to Enhance Adherence to Glaucoma Treatment
NCT04245163 ·Status: UNKNOWN ·Phase: NA
-
Study on Incentives for Glaucoma Medications Adherence
NCT02271269 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
NCT04552964 ·Status: COMPLETED ·Phase: NA
-
Effect of Glaucoma Educators on Adherence to Prescribed Therapeutic Regimens in Glaucoma Patients
NCT00454922 ·Status: COMPLETED ·Phase: NA
-
An App-based Instructional Platform to Improve Eye Drop Recall
NCT06045390 ·Status: COMPLETED ·Phase: NA
-
Effect on the Adherence to Glaucoma Eye Drops by Improving Patient Understanding and Using a Tele-reminder System
NCT04317573 ·Status: COMPLETED ·Phase: PHASE2
-
Steroid Eyedrop Adherence After Trabeculectomy
NCT03402802 ·Status: COMPLETED
-
Improving Access to Eye Care in Glaucoma Patients
NCT02982629 ·Status: COMPLETED ·Phase: NA
-
Real-time Glaucoma Medication Adherence
NCT03194828 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia
NCT04675151 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Adherence to Clinical Treatment of Glaucoma
NCT03338088 ·Status: UNKNOWN
-
Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopia Using Optical Coherence Tomography Angiography (OCTA) And Visual Evoked Potential (VEP). The Aim Of The Study Is To Evaluate Possible Beneficial Effects For Different Age Groups.
NCT07417046 ·Status: RECRUITING ·Phase: NA
-
Glaucoma Eye Drop Instillation: Impact of Education
NCT01416415 ·Status: TERMINATED ·Phase: NA
-
Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study
NCT05695027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
The Flashing Light-Induced Pupil Response (FLIPR) Glaucoma Study
NCT01857440 ·Status: COMPLETED
-
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora
NCT02240615 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Detection of Glaucoma Using Pupillography
NCT01462526 ·Status: COMPLETED
-
Compliance and Administration Technique in Topical Drug Therapy of Glaucoma
NCT00303121 ·Status: COMPLETED
-
The Effect of "Eye Drop Guide" on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients
NCT01704248 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Biofeedback Training for Glaucoma
NCT07409077 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia
NCT05646719 ·Status: COMPLETED ·Phase: PHASE3
-
Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
NCT02396316 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy
NCT05793359 ·Status: COMPLETED
-
Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients
NCT01714960 ·Status: COMPLETED ·Phase: PHASE1
-
Personality Characteristics and Compliance With Antiglaucoma Medication
NCT00481494 ·Status: UNKNOWN